Posted On: July 10, 2026
Some patients come to me carrying years of lab results, imaging reports, and specialist notes, and yet no one has ever put the picture together. Others hear “everything looks normal” at every visit, even though something clearly feels off. In both cases, the missing ingredient is often the same: care that accounts for who you actually are, not just what the standard chart says.
That is what precision medicine is about. It is the practice of tailoring prevention and treatment to a person’s genetics, environment, and lifestyle. It uses advances in genomic testing and technology to go deeper than routine care typically allows. Personalized care has always been the goal of good primary care. Today’s tools simply make it possible to practice that care with far more depth and accuracy than before.
In this post, I want to walk you through what precision medicine means, how it works in practice, and why I believe it represents a meaningful shift in how we keep people well, not just treat them when they are sick.
Precision medicine draws on three factors that make each of us different: our genetics, our environment, and our lifestyle1. When those three are understood together, supported by advanced testing and technology, care becomes far more targeted and effective.
I find it helpful to think of precision medicine through four principles, sometimes called the four Ps2:
The following sections walk through each of the three core factors in turn: your genes, your environment, and your lifestyle. Traditional medicine applies population-level guidelines to everyone. Precision medicine uses those guidelines as a starting point, then builds on them with the context that makes you unique.
Genetic and genomic testing looks at your DNA, or in the case of cancer, at the molecular profile of a tumor, to guide prevention and treatment decisions. This is different from the routine bloodwork most people are used to. Standard labs give us a snapshot of how your body is functioning right now. Genetic markers reveal what you carry in your DNA, often from birth, and what that means for your long-term health.
Some of those markers show up as elevated risk for specific conditions. Lipoprotein(a), for example, is a genetically driven cardiovascular risk factor that a standard cholesterol panel does not capture. ApoE variants influence both cardiovascular and cognitive risk. A routine set of numbers can look perfectly fine while inherited risk goes undetected.
Genetics also has a growing role in heart health. For example, if a patient has inherited conditions of the heart muscle and heart rhythm, known as cardiomyopathies and channelopathies, I can order more explicit genetic testing which can identify if it’s a risk that runs in families. When a result points to something, I make sure you have the option to meet with a genetic counselor to understand what it means for you and your relatives.
In the area of cancer, genetic testing has changed what early prevention looks like. Variants in BRCA1 and BRCA2 can alter how and when someone begins screening for breast and ovarian cancer, sometimes by a decade or more. These same variants are inherited through the male line as well, and men who carry them face higher risk of prostate, pancreatic, and male breast cancer3. That is one reason I take a full family history, on both sides. When cancer is already present, tumor markers like HER2 help determine which treatment is most likely to work for that specific cancer, not cancers in general.
Family history is often the most accessible first genetic test a person has. It reflects the genes a family shares but also the environments and habits passed down through generations. That combination is what makes it a thread across all three factors. In my practice, family history helps me decide which genetic tests are worth ordering, and when earlier screening makes sense, before anything has had a chance to develop.
Environment covers everything outside your own biology: where you live and work, the air and water quality you encounter, the physical and chemical exposures you face, and the social and economic factors that shape your daily life.3 Factors such as income level, access to education and healthcare, gender or racial discrimination all have an impact on the quality of care people receive. Two people with similar genetics can have very different health trajectories based on their environments alone.
Stress load, access to green space, noise exposure, occupational hazards, and neighborhood safety. These factors are not separate from health. They are health. Precision care means taking them seriously alongside lab results and genetic data, because no test result exists in isolation from the life around it.
The daily choices within your control, including what you eat, how you move, how you sleep, and how you manage stress, influence your health at a molecular level. Lifestyle choices can turn genetic risk factors up or down. They affect inflammation, insulin sensitivity, hormone balance, and cognitive resilience.
What precision medicine adds to this conversation is specificity. Generic advice to eat better and exercise more helps no one in particular. What works better is understanding your individual metabolic response to food, your body composition, your sleep architecture, and your stress physiology, and building guidance around that picture. That is the difference between a recommendation and a plan., and it’s why we offer our members complimentary yearly nutrition and functional fitness consults as well as body composition testing.
One of the most practical applications of precision medicine in primary care is pharmacogenomics, which is the study of how your genes affect the way your body processes medications. Different people carry different variants in the genes that metabolize drugs. Some break a medication down so quickly it never reaches a level that helps, others process it so slowly that a standard dose causes side effects.
This is more common than most people expect. According to the American Heart Association’s 2025 policy statement on the topic, more than 95%4 of us carry at least one genetic variant that is meaningful for prescribing. The most practical way to capture that information is a preemptive multigene panel: a single test, often a cheek swab or blood draw, that can guide prescribing decisions for the rest of your life. These variants show up across medications people take all the time, including clopidogrel (Plavix), statins, antidepressants, and some pain medications.
When I have this information, it changes how I prescribe in a concrete way. If your genetics make you a slow metabolizer of a particular drug, we start at a lower dose or sometimes choose a different medication. If you are a rapid metabolizer, you may need a higher dose to reach a level that works. It moves a decision that has often been trial and error closer to an informed first choice.
Currently, I use pharmacogenomic testing selectively, most often for patients who need clopidogrel, but it deserves wider use, especially for anyone on a statin, an antidepressant, or a pain medication who is having side effects. I expect it to become a more routine part of primary care in the future.
Precision medicine increasingly draws on real-time data and technology, not just one-time tests. Wearables and continuous monitoring devices give us a moving picture of how your body responds to food, activity, stress, and sleep. A single measurement at a single point in time cannot capture those patterns.
The same principle applies to your routine labs. A single result can sit inside the normal range and still be worth watching if it has been drifting year over year in the wrong direction. Because I follow your numbers over time rather than reading them in isolation, we can catch that kind of trend early, often before it crosses into a diagnosis.
One example I find particularly valuable is continuous glucose monitoring. Rather than a single fasting glucose number, a continuous monitor shows how your blood sugar responds to different foods, stress, exercise, and sleep quality over days and weeks. That level of detail allows for highly specific, personalized guidance that generic nutrition recommendations simply cannot match.
As these tools become more accessible, they add a meaningful layer to the clinical picture, helping us catch patterns early and adjust recommendations in real time rather than waiting for the next annual visit.
The honest answer is that this is already how I practice medicine, even before the term “precision medicine” existed. The difference now is that I have better tools to do it with.
The foundation of that approach is time. My annual exams run 60 to 90 minutes, two to three times longer than a standard visit. That time is not a luxury. It is what makes it possible to understand your full picture: your family history, your genetics, your lifestyle, your environment, and how all of those interact. A 15-minute visit cannot hold that conversation.
At your first comprehensive annual exam, we work through an in-depth assessment covering cardiovascular risk, body composition, hereditary cancer risk (including a breast cancer risk assessment), and screening questions on sleep apnea, mood, fracture risk, and sexual health. Your membership also includes a nutrition consultation and a functional fitness assessment. In the years that follow, we revisit each area and update it as needed, briefly when things have been stable and in more depth when something has changed. This is how I build a complete picture of your health, so that any targeted testing we order later is grounded in context.
From there, I can draw on more targeted tools when your individual risk warrants it. A coronary artery calcium scan adds specificity to cardiovascular risk beyond what standard cholesterol panels show. DXA imaging with FRAX fracture scoring gives a precise picture of bone density and fracture probability. Genetic testing for hereditary cancer risk, pharmacogenomic panels, and advanced lipid testing all inform care when the conversation points in that direction.
The ongoing relationship is what makes all of this meaningful. Risk changes over time. New information emerges. Screenings come due. Precision medicine is not a one-time test. It is an evolving picture built over years of knowing you.
For most of modern medicine, research was done largely in men. Women were formally kept out of early clinical trials for years, a practice that began with a 1977 FDA policy, and even today they make up only about a third of participants in early-phase studies5. Many standard treatment guidelines were built on data that did not fully represent the patients they were meant to serve.
Precision medicine changes that equation because it centers the individual. Your biology, your risk profile, your hormone transitions, and your genetic markers are the inputs, not a population average that may or may not reflect your physiology.
In my practice, this shows up most clearly in a few areas. Medications do not behave the same way in everybody — women often absorb, metabolize, and clear drugs differently6, which is exactly where pharmacogenomics and thoughtful dosing matter. Cardiovascular disease carries female-specific genetic and risk patterns that standard guidelines have been slow to reflect7. And emerging research8 suggests women’s brains may even age differently at the molecular level.
Hereditary cancer risk still belongs in the conversation, since a family history of breast, ovarian, or endometrial cancer can change your screening plan, though those same genes affect men, too. Each year, we revisit your breast cancer risk with a short questionnaire and reassess if anything has changed.
The menopause transition is another place where precision matters enormously. As estrogen declines, cardiovascular risk rises, bone density shifts, and metabolic health changes. Those changes do not happen the same way in every woman or on the same timeline. Genetic insight into how you metabolize hormones, how your cardiovascular risk profile is shifting, and how your bones are responding allows me to make hormone therapy and prevention decisions that are genuinely personalized. This focus on women’s health is not incidental to my practice. It is why I built it.
I want to be clear about something, because this matters. Precision medicine does not replace the fundamentals of good health. Sleep, nutrition, movement, stress management, and strong relationships are still the most powerful tools most of us have. No genetic test changes that. Precision medicine adds depth to those foundations, however it is not a substitute for them.
It is also not something you should try to navigate alone. Genetic results, pharmacogenomic reports, and advanced biomarkers all require a clinician who understands your full picture to interpret them meaningfully. Data without context is noise. In my practice, that interpretation happens within a relationship built over time, which is what makes the results actionable rather than just informative.
And perhaps most importantly: precision medicine is not only for people who are already unwell. Much of its value lives in prevention, in finding the signal before it becomes a problem, and in building a plan that keeps you well rather than one that responds after the fact.
The terms are often used interchangeably, and the distinction is subtle. Personalized medicine broadly refers to care tailored to the individual. Precision medicine is a more specific term that emphasizes using genetic, molecular, environmental, and lifestyle data to guide clinical decisions. In practice, they describe the same goal: care that fits you.
No. In fact, much of the value of precision medicine lies in prevention. Identifying elevated cardiovascular risk, hereditary cancer risk, or metabolic vulnerability before symptoms appear is exactly where early action has the greatest impact. The goal is to intervene at the point of risk, not wait for disease to develop.
Pharmacogenomic testing typically involves a simple cheek swab or blood draw. The sample is analyzed for genetic variants in the enzymes responsible for metabolizing specific medications. Results usually return within a few weeks and are then interpreted alongside your current or planned medications. In my practice, I use pharmacogenomic results to inform prescribing decisions, particularly for medications where genetic variation has a meaningful impact on response or side effects.
A result showing elevated risk is not a diagnosis. It is information, and in most cases it is information we can act on constructively. Knowing that you carry BRCA variants, for example, allows us to start screening earlier, consider preventive options, and monitor more closely. In my experience, most patients feel more empowered by knowing than by not knowing. That said, I never order genetic testing without a plan for how we will respond to the results, whatever they show.
The way I think about my practice comes back to a simple idea: the best time to understand your health is before something goes wrong. Precision medicine gives us the tools to do exactly that: to see your genetic risk, understand your environment and lifestyle, and build a prevention plan that fits who you are.
Those four principles I mentioned at the beginning, predictive, preventive, personalized, and participatory, are not just a framework for genomic medicine. They are a description of what good primary care has always aspired to be. What has changed is that we now have the science, the testing, and the technology to practice it with far greater precision.
Whether or not you are a patient of mine, the takeaway is the same: the best time to understand your health is before something goes wrong, and the tools to do that have never been better.
Leading the way in women's healthcare is renowned board-certified internal medicine doctor Dr. Eileen West. She has over 20 years of experience and is recognized for her expertise in menopause, osteoporosis, and cardiovascular disease prevention. Her excellence-driven compassionate approach, which is associated with the American College of Physicians, improves the lives of her patients by putting a strong emphasis on their overall well-being.
Location: Fairfax, Virginia
Areas of Expertise: Women's Health, Menopause Management, Cardiovascular Disease Prevention, Osteoporosis Diagnosis and Treatment.
Join our Email Newsletter to get the latest and greatest tips on ways to maximize your health, invitations to educational events, and other practice news!
By submitting this form, you are consenting to receive marketing emails from Eileen West, MD and Associates.
